Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class ASSE: 688621

for STC008 Injection

· Issued by Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on the Signing of the “Supplementary Agreement to the Technology Development Contract” for STC008 Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment